Jay Lutsky
Nessuna posizione attualmente
Profilo
Jay Lutsky was a Director of Sinocom Pharmaceutical, Inc. until March 13, 2009.
He was President of Sunburst Acquisitions and Eagle Venture Acquisitions.
He was Secretary and Treasurer of Sunburst Acquisitions II.
Mr. Lutsky was an Executive Lending Officer at the United Bank of Denver from 1968 to 1974.
He received a degree from Kent State University in 1967.
Precedenti posizioni note di Jay Lutsky
| Società | Posizione | Fine |
|---|---|---|
Sinocom Pharmaceutical, Inc.
 Sinocom Pharmaceutical, Inc. Medical DistributorsDistribution Services Sinocom Pharmaceutical, Inc. operates as a holding company with interest in selling and distributing pharmaceutical products. The firm, through its subsidiaries, sells and distributes herbs, traditional Chinese medicines, western pharmaceutical products and medical supplies to customers located in the provinces of Anhui, Jiangxi, Hubei, Zhejiang and Jiangsu. The company supplies its products to hospitals, pharmacies and medical clinics. It also manages TCM raw herb plantations. The company was founded in 1986 and is headquartered in Hong Kong. | Direttore/Membro del Consiglio | 13/03/2009 |
Percipio Biotherapeutics, Inc.
 Percipio Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Percipio Biotherapeutics, Inc. manufactures botanical medicinal products. The firm is a development-stage biotechnology company. It is engaged in preclinical development of PB102 and PB108 an anti-CD55 chimeric monoclonal antibody, including the preparation and revision of clinical development plans. The company was founded on August 27, 1997 and is headquartered in Los Angeles, CA | Presidente | 08/02/2005 |
| ABCO ENERGY, INC. | Presidente | - |
Esperienze
Posizioni ricoperte
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABCO ENERGY, INC. | Utilities |
| Aziende private | 2 |
|---|---|
Percipio Biotherapeutics, Inc.
Percipio Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Percipio Biotherapeutics, Inc. manufactures botanical medicinal products. The firm is a development-stage biotechnology company. It is engaged in preclinical development of PB102 and PB108 an anti-CD55 chimeric monoclonal antibody, including the preparation and revision of clinical development plans. The company was founded on August 27, 1997 and is headquartered in Los Angeles, CA | Health Technology |
Sinocom Pharmaceutical, Inc.
Sinocom Pharmaceutical, Inc. Medical DistributorsDistribution Services Sinocom Pharmaceutical, Inc. operates as a holding company with interest in selling and distributing pharmaceutical products. The firm, through its subsidiaries, sells and distributes herbs, traditional Chinese medicines, western pharmaceutical products and medical supplies to customers located in the provinces of Anhui, Jiangxi, Hubei, Zhejiang and Jiangsu. The company supplies its products to hospitals, pharmacies and medical clinics. It also manages TCM raw herb plantations. The company was founded in 1986 and is headquartered in Hong Kong. | Distribution Services |
- Borsa valori
- Insiders
- Jay Lutsky
